ENOV

Enovis Corp
NYSEHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$1.63B
P/E Ratio
EPS
$-19.89
Beta
1.50
52W High
$34.28
52W Low
$19.14
50-Day MA
$23.86
200-Day MA
$25.51
Dividend Yield
Profit Margin
-49.90%
Forward P/E
7.33
PEG Ratio
1.90

About Enovis Corp

Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.28B
Gross Profit (TTM)$1.39B
EBITDA$372.25M
Operating Margin3.64%
Return on Equity-55.30%
Return on Assets1.09%
Revenue/Share (TTM)$39.83
Book Value$25.66
Price-to-Book1.05
Price-to-Sales (TTM)0.71
EV/Revenue1.288
EV/EBITDA22.42
Quarterly Earnings Growth (YoY)153.10%
Quarterly Revenue Growth (YoY)5.40%
Shares Outstanding$57.56M
Float$56.59M
% Insiders1.63%
% Institutions121.12%

Historical Volatility

HV 10-Day
63.00%
HV 20-Day
93.81%
HV 30-Day
82.15%
HV 60-Day
75.19%
HV Rank
96.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($40.73 target)
2
Strong Buy
8
Buy
1
Hold

Latest News

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2026 financial results on Thursday, August 6th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

GlobeNewsWire7/17/2026Neutral
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

DALLAS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, today announced the U.S. launch of CT-RevitL™, the next-generation veterinary PBM laser therapy system from its Companion Animal Health business. CT-RevitL delivers enhanced clinical performance, greater mobility and a more intuitive treatment experience for veterinary teams and their patients.

GlobeNewsWire7/13/2026Neutral
Enovis Announces First Quarter 2026 Results

Dallas, TX, May 07, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended April 3, 2026. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

GlobeNewsWire5/7/2026Neutral
Despite Fast-paced Momentum, Enovis (ENOV) Is Still a Bargain Stock

Enovis (ENOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Investment Research4/22/2026Positive
Enovis to Host First Quarter 2026 Results Conference Call on May 7th

Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2026 financial results on Thursday, May 7th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at  www.enovis.com .

GlobeNewsWire4/10/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ENOV and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026